Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.
about
The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial diseaseRecent advances in central cardiovascular control: sex, ROS, gas and inflammationDendritic Cells and Their Role in Cardiovascular Diseases: A View on Human StudiesInfiltrating immune cells in the kidney in salt-sensitive hypertension and renal injuryInflammation, immunity, and hypertensive end-organ damageInflammation and hypertension: new understandings and potential therapeutic targetsTargeting NADPH oxidases in vascular pharmacologyHypertension: what's sex got to do with it?An update on immune system activation in the pathogenesis of hypertensionDarkness at the end of the tunnel: poststenotic kidney injuryImmune activation caused by vascular oxidation promotes fibrosis and hypertensionImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisThe inextricable role of the kidney in hypertensionNovel adaptive and innate immunity targets in hypertension.Do high-salt microenvironments drive hypertensive inflammation?Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations.Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.Role of the immune system in hypertension: modulation by dietary antioxidants.Interleukin 17 in vascular inflammation.Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase.Upregulation of OLR1 and IL17A genes and their association with blood glucose and lipid levels in femoropopliteal artery diseaseDual opposing roles of adaptive immunity in hypertension.Cutaneous control of blood pressure.Role of vascular oxidative stress in obesity and metabolic syndrome.Aldosterone and inflammation.A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damageInteractions of hyperhomocysteinemia and T cell immunity in causation of hypertensionThe immune system in hypertensionRoles of inflammation, oxidative stress, and vascular dysfunction in hypertension.Sex-specific T-cell regulation of angiotensin II-dependent hypertension.Female spontaneously hypertensive rats have a compensatory increase in renal regulatory T cells in response to elevations in blood pressure.Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular systemInterleukin-2/Anti-Interleukin-2 Immune Complex Expands Regulatory T Cells and Reduces Angiotensin II-Induced Aortic Stiffening.The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patientsIs hypertension an autoimmune disease?Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease.Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation.DC isoketal-modified proteins activate T cells and promote hypertension.Inflammation, immunity, and hypertension.Irreversible renal damage after transient renin-angiotensin system stimulation: involvement of an AT1-receptor mediated immune response.
P2860
Q26745592-B4411A8B-F240-4151-8C18-B1B662DE55C7Q26752442-615FAAFF-19B4-42A2-AD8F-D9193D432496Q26752811-8D831C02-F163-4737-9792-4B1C662948EBQ26822514-F960CD42-F965-4D42-8738-C2D8CD7911ABQ26827525-25FD2301-0842-4D26-BE43-EB5887055D95Q26827586-DA36387C-E014-410A-9F17-9FA07B7F3870Q26863500-3EBCEC60-1114-43DF-9E8B-498A5CABD394Q26866656-78119910-F108-40E7-B4EE-52C8C074276CQ27013715-EF9167A4-B334-442B-A0A7-7C6F6EE8C993Q27014398-B793B260-7755-40A3-8394-E440AF8F2C7BQ27332212-74ABD0F2-D04C-438E-A8C2-9EFC6188F7F8Q28084366-A4B77D51-3E07-4E8E-88D5-252111C88D7AQ28241252-FC8B0E86-D8D0-432F-A97D-ACFBA193F1D7Q30235116-F0C6617E-7EC5-49F9-AC1F-EE2062D4B069Q30240293-B6B6B504-8592-4790-B0ED-9A2163D849EAQ30252415-7FC2511C-4924-4771-8448-9EC6DBC66530Q30365965-62746BEE-BA04-4242-BF76-A839E417121CQ30424339-2BE089F6-22F2-495F-B08B-B382155D31F8Q30429445-34991D73-70BF-419D-A697-427613DFABE6Q30589228-C3514D6E-3045-4043-BF36-A29CF9B273DAQ33598191-A10898B4-5B1D-4CCC-9B4C-C4EEE6F17D4BQ33606181-22AB1C5B-AEFA-4CB5-891B-FF1D678780E0Q33690138-532FB709-9EAA-4764-9AF7-82156C6A9F84Q33789308-B92CCB71-A1B7-4985-A609-2D79F5526A1AQ33837784-F7028939-E03A-4395-9A81-A9E30B58F758Q33877762-F74F1E9D-9FA3-4810-922E-72B85406875FQ33920630-116F1555-295D-4C4D-BB27-C84E6CFFC942Q33957722-E86A1218-958F-4592-B98C-110E09BE9DCBQ34013918-0A71C762-0FA5-4C95-ADF2-DD15C0DBEF89Q34047021-A03FBD3C-4DCA-4744-90C6-520E2D29A94DQ34051321-A5AECB4C-1FDD-45C4-9C2D-FFC9E022891EQ34062829-8E58716C-3251-4B95-A3FC-C721BC21F0BCQ34203364-56BCC109-265C-4CD5-8761-CE4B2A09F411Q34309016-BE304412-64D4-4CA5-91A7-2CDC0066626CQ34311505-8F5A0E59-6752-42FC-B973-B7B9B012AFC7Q34381424-D5075288-9B28-4E2C-AB98-07353DE337C0Q34419313-E0138E7D-9CF8-4CAF-87F6-61E32EED698EQ34454645-9A5EE4EC-6E89-4D0A-9288-673B361911B1Q34528283-68CD7789-2ECF-4F61-A661-DD057F29D79EQ34612453-AA3E9E76-B692-4CBB-81FD-67FA0CC49B49
P2860
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.
@ast
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.
@en
type
label
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.
@ast
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.
@en
prefLabel
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.
@ast
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.
@en
P2093
P2860
P1433
P1476
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.
@en
P2093
David G Harrison
Heinrich E Lob
Louise A McCann
Tomasz J Guzik
Yelena Blinder
P2860
P304
P356
10.1161/HYPERTENSIONAHA.109.145094
P407
P577
2009-12-28T00:00:00Z